Marshall Wace
MYOK

Marshall Wace’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Marshall Wace’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-142,028
Closed -$13.7M – 2086
2020
Q2 		$13.7M Buy
+142,028
New +$11.8M 0.1% 221
2020
Q1 		– Sell
-30,073
Closed -$2.19M – 2256
2019
Q4 		$2.19M Sell
30,073
-64,041
-68% -$3.88M 0.02% 783
2019
Q3 		$4.91M Sell
94,114
-85,946
-48% -$4.57M 0.04% 512
2019
Q2 		$9.03M Sell
180,060
-275,359
-60% -$13.4M 0.07% 311
2019
Q1 		$23.7M Buy
+455,419
New +$21M 0.22% 90
2017
Q1 		– Sell
-121,304
Closed -$1.57M – 874
2016
Q4 		$1.57M Buy
121,304
+21,304
+21% +$328K 0.01% 685
2016
Q3 		$1.63M Buy
+100,000
New +$1.81M 0.01% 641

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Marshall Wace's MYOK Position: Q3 2020 in Review

Marshall Wace sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 142,028 shares — an estimated $13.7M sold.

Marshall Wace first reported a position in MYOK in Q3 2016 and held it in 7 quarters. The position peaked at $23.7M in Q1 2019. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Marshall Wace reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Marshall Wace sold 142,028 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $13.7M.
  • Marshall Wace first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 7 quarters.
  • Marshall Wace's MyoKardia, Inc. Common Stock position peaked at $23.7M in Q1 2019.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Marshall Wace's 13F filing for Q3 2020, filed 16 Nov 2020.